• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

What’s in Store at ACC.11: Lecture on Global Health and Equality

Article

Global humanitarian James Orbinski, MD, will deliver the Franz M. Groedel Presidential Plenary Lecture at this year's Scientific Showcase Session on Sunday, April 3.

Global humanitarian James Orbinski, MD, will deliver the Franz M. Groedel Presidential Plenary Lecture at this year's Scientific Showcase Session on Sunday, April 3. Dr Orbinski practices clinical medicine and is a research scientist at St. Michael's Hospital, University of Toronto. He is an associate professor of medicine, political science and public health at the University of Toronto and is also a senior fellow at the University of Toronto's Massey College and at the Munk Centre for International Studies. Dr Orbinski is the former international president of Doctors Without Borders and in 1999 accepted the Nobel Peace Prize on the organization's behalf.

Dr Orbinski's lecture will focus on "Global Health and Equality-Which Way Forward?" He believes that access to health care and to essential health technologies is critical to global health issues today, especially for people living in poverty. His research interests focus on access to medicines and health care, medical humanitarianism in war and social crisis and global health policy.
 

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.